Affinity Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Affinity Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,980	Closed	-$207K	–	134
2023 Q1	$207K	Buy	+2,980	New	+$210K	0.06%	117
2020 Q1	–	Sell	-3,164	Closed	-$203K	–	102
2019 Q4	$203K	Buy	+3,164	New	+$181K	0.13%	111

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Affinity Capital Advisors's BMY Position: Q2 2023 in Review

Affinity Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 2,980 shares — an estimated $207K sold.

Affinity Capital Advisors first reported a position in BMY in Q4 2019 and held it in 2 quarters. The position peaked at $207K in Q1 2023. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Affinity Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Affinity Capital Advisors sold 2,980 Bristol-Myers Squibb shares in Q2 2023, an estimated $207K.
Affinity Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 2 quarters.
Affinity Capital Advisors's Bristol-Myers Squibb position peaked at $207K in Q1 2023.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Affinity Capital Advisors's 13F filing for Q2 2023, filed 14 Jul 2023.